The Technical Analyst
ENDRA Life Sciences Inc [NDRA]
Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Diagnostics & Research
ENDRA Life Sciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-4.57% $0.190
Last updated: 16 May 2022 @ 11:05 am
FIND ALL MARKETS
FIND ALL STOCKS LISTED @ NASDAQ Live Signal Oslo
Live Signal Nasdaq
Live Signal Crypto
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 12.00 mill |
| EPS: | -0.277 |
| P/E: | 0.000 |
| Earnings Date: | May 12, 2022 |
| SharesOutstanding: | 63.17 mill |
| Avg Daily Volume: | 2.75 mill |
| RATING 2022-05-13 |
|---|
| B |
| Neutral |
| RATINGDETAILS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/20 | 1/21 | 2/21 | 3/21 | 4/21 | 1/22 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt |
| True Range Average |
|---|
|
+/- $0.0370 ( +/- 18.59%) Range: 0.162 - 0.236 |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-03-28 | Maloberti Renaud Bertrand | Buy | 186 430 | Stock Options |
| 2022-03-28 | Thornton Michael Milos | Buy | 698 102 | Stock Options |
| 2022-03-28 | Basenese Lou | Buy | 74 500 | Stock Options |
| 2022-03-28 | Harsh Michael | Buy | 109 492 | Stock Options |
| 2022-03-28 | Pestrikova Irina | Buy | 41 500 | Stock Options |
| INSIDER POWER |
|---|
| 81.47 |
| Last 100 transactions |
| Buy: 5 483 590 | Sell: 474 712 |
Forecast:
12:40 - $0.193
Live Trading Signals (every 1 min)
Forecast
1: 11:10 - $0.190
Forecast 2: 12:00 - $0.190
Forecast 3: 12:40 - $0.193
SCORE
-10.00
Sell
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.190 (-4.57% ) |
| Volume | 0.308 mill |
| Avg. Vol. | 2.75 mill |
| % of Avg. Vol | 11.19 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NDRA
228 Signals | Accuracy: 15.35% | Accuracy Buy: 16.67% | Accuracy Sell: 14.04%
Avg return buy: -0.86 % | Avg return sell: 0.66 %
$1 invested is now $0.37 or -63.12% since 20-04-22
| Date | Signal | @ | Closed | % | May 16 - 09:45 | sell | $0.198 | $0.198 @ May 16 - 09:53 | 0.05% |
|---|---|---|---|---|
| May 16 - 09:39 | buy | $0.200 | $0.198 @ May 16 - 09:44 | -0.85% |
| May 13 - 16:53 | sell | $0.199 | $0.200 @ May 16 - 09:30 | 0.50% |
| May 13 - 16:04 | buy | $0.199 | $0.199 @ May 13 - 16:52 | 0.00% |
| May 13 - 15:11 | sell | $0.190 | $0.199 @ May 13 - 16:00 | 4.74% |
| May 13 - 14:51 | buy | $0.195 | $0.190 @ May 13 - 15:10 | -2.36% |
| May 13 - 10:46 | sell | $0.208 | $0.195 @ May 13 - 14:50 | -6.31% |
| May 13 - 10:10 | buy | $0.202 | $0.208 @ May 13 - 10:45 | 3.03% |
| May 13 - 09:55 | sell | $0.198 | $0.202 @ May 13 - 10:09 | 1.92% |
| May 13 - 09:51 | buy | $0.210 | $0.198 @ May 13 - 09:54 | -5.58% |
NDRA
Latest Press Releases
2022-05-10 08:00:00 - Press Release
Endra Life Sciences Issued Additional U.s. And Chinese Patents For Its Taeus® System
Ann arbor, mich.--(business wire)---- $ndra #nalfd--endra life sciences inc. (nasdaq: ndra), a pioneer of thermo acoustic enhanced ultrasound (taeus®), announces the issuance of four new patents, two in the u.s. and two in china. endra's intellectual property portfolio now includes 90 assets, including 46 issued patents worldwide providing protection for the taeus system with its novel hybrid ultrasound and thermoacoustic imaging technology. one of the newly issued u.s. patents, which protects the ability to tr
2022-03-31 08:00:00 - Press Release
Endra Life Sciences Achieves Key Quality Management System Certification
Ann arbor, mich.--(business wire)---- $ndra #nafld--endra life sciences inc. (nasdaq: ndra), a pioneer of thermo acoustic enhanced ultrasound (taeus®), announces receipt of medical device quality management system iso 13485:2016 and en iso 13485:2016 recertification, under certificate number md 697226 from the british standards institution (bsi). this recertification affirms the company's quality management system (qms) meets all current regulatory requirements specific to the medical device industry. the u.s.
2022-03-30 16:05:00 - Press Release
Endra Life Sciences Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Business Update
Ann arbor, mich.--(business wire)---- $ndra #nafld--endra life sciences inc. (nasdaq: ndra), a pioneer of thermo acoustic enhanced ultrasound (taeus®), today reported financial results for the three months and year ended december 31, 2021 and provided a business update. highlights of the fourth quarter of 2021 and recent weeks include: achieved clarity on the u.s. regulatory strategy for the taeus system. after extensive and productive dialogue with the u.s. food and drug administration (fda), endra is now purs
2022-03-30 09:12:00 - Press Release
Endra Life Sciences Strengthens Taeus® System Global Intellectual Property Protection With Issuance Of 10th And 11th Chinese Patents
Ann arbor, mich.--(business wire)---- $nafld #ndra--endra life sciences inc. (nasdaq: ndra), a pioneer of thermo acoustic enhanced ultrasound (taeus®), announces that the chinese national intellectual property administration has issued endra two new patents, chinese patent no. zl 2019 8 00400927 (the ‘927 patent) titled “method and system for determining fractional fat content of tissue,” and chinese patent no. zl 2019 8 00870250 (the ‘250 patent) titled “radio frequency applicator and thermoacoustic imaging sy
2022-02-15 08:55:00 - Press Release
The Stock Day Podcast Hosted Endra Life Sciences Inc. To Discuss The Potential Of Its Thermo Acoustic Enhanced Ultrasound (taeus(r))
Phoenix, arizona--(newsfile corp. - february 15, 2022) - the stock day podcast welcomed endra life sciences inc. (nasdaq: ndra) ("the company"), the pioneer of thermo; acoustic enhanced ultrasound (taeus®), a ground-breaking technology being developed to visualize tissue like mri, but at 1/50th the cost and at the point of patient care. ceo of the company, francois michelon, joined stock day host everett jolly.jolly began the interview by asking about the company's decision to focus...
Latest News
2022-05-12 22:37:16 - Seeking Alpha
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2022 Results - Earnings Call Transcript
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike Thornton - Chief Technology Officer Renaud Maloberti - CCO Irina Pestrikova - Senior Director, Finance Conference Call Participants Vernon Bernardino - H.C. Wainwright Edward Woo - Ascendiant Capital Operator Good afternoon everyone, and welcome to the ENDRA Life Sciences' First Quarter 2022 Financial Results Conference Call.
2022-04-08 09:31:17 - PennyStocks
Trading Penny Stocks on April 8th? What to Know on Friday
Here's what you need to know about trading penny stocks on April 8th The post Trading Penny Stocks on April 8th? What to Know on Friday appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-03-30 19:07:09 - Seeking Alpha
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q4 2021 Earnings Call Transcript
2022-03-09 08:00:00 - Business Wire
ENDRA Life Sciences to Participate in Two March Investor Conferences
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two investor conferences during March: 34th Annual ROTH Conference, March 13-15, 2022 at The Ritz-Carlton Laguna Niguel. Management will be available for one-on-one meetings on Monday, March 14, 2022. In addition, a pre-recorded company presentation will be available in the Investors section of ENDRA's website here.
2022-01-05 07:00:00 - Business Wire
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. A webcast of the presentation will be available on-demand beginning January 10, 2022 at 7:00 a.m. Eastern time on the Investors section of ENDRA's website. About ENDRA Life Sciences Inc. ENDRA Life Sciences is the pioneer of
2021-12-30 09:12:04 - Zacks Investment Research
Forget Bargains, Play 5 Stocks With Rising P/E Instead
2021-11-15 21:35:31 - Seeking Alpha
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q3 2021 Results - Earnings Call Transcript
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q3 2021 Results - Earnings Call Transcript
2021-11-15 20:01:08 - Zacks Investment Research
ENDRA Life Sciences Inc. (NDRA) Reports Q3 Loss, Misses Revenue Estimates
ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
2021-09-07 08:00:00 - Accesswire
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two upcoming virtual investment conferences. H.C. Wainwright 23rd Annual Global Investment Conference, September 13 - 15, 2021.
2021-08-12 21:31:07 - Seeking Alpha
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q2 2021 Results - Earnings Call Transcript
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q2 2021 Results - Earnings Call Transcript